Drug
Satavaptan clinical trials
Also written SR121463B.
- studies test it
- 11
- open now
- 0
- in phase 3
- 7
- first study started
- 2001
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2004 (4)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 3 |
| 2008 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
- Phase 3
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Studies
Open first, then newest update. How each study uses satavaptan is read from its arms, and is right about nine times in ten.
Testing it · 11
- Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)CompletedPhase 3SanofiNCT00358878Written as Satavaptan
- A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional HyponatremiaTerminatedPhase 3SanofiNCT00728091Written as Satavaptan
- Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the LiverTerminatedPhase 3SanofiNCT00359437Written as Satavaptan
- Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the LiverTerminatedPhase 3SanofiNCT00366795Written as Satavaptan
- Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCompletedPhase 3SanofiNCT00264914Written as SR121463B
- Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic AscitesCompletedPhase 2SanofiNCT00501722Written as satavaptan (SR121463B)
- Satavaptan Dose-Ranging Study in the Prevention of AscitesCompletedPhase 2SanofiNCT00501384Written as satavaptan (SR121463B)
- Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCompletedPhase 3SanofiNCT00264927Written as SR121463B
- DILIPO (DILutIonal HyPOnatremia)CompletedPhase 3SanofiNCT00274326Written as SR121463B
- Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCompletedPhase 2SanofiNCT00032734Written as satavaptan (SR121463B)
- Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic AscitesCompletedPhase 2SanofiNCT00501566Written as satavaptan (SR121463B)
Codes
What other systems call satavaptan · ClinicalTrials.gg INT003950
- MeSH (NLM) C103281satavaptanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) AJS8S3P31HSATAVAPTANConfirmed FDA, NLM, Wikidata
- Wikidata Q7425965Satavaptan fumarateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C80380SatavaptanOne source FDA
- DrugBank DB14923One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C103281 | satavaptan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | AJS8S3P31H | SATAVAPTAN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7425965 | Satavaptan fumarate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C80380 | Satavaptan | One source FDA |
| DrugBank | DB14923 | — | One source Wikidata |
Also registered as satavaptan phosphate (UNII EY1272I0W2).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.